财经首页
|
新浪首页
|
新浪导航
财经首页
美股首页
滚动
评论
经济数据
美股列表
中国概念股
美股行情中心
美股自选
(ADAP)
公司资讯
finviz | 2022年09月09日 22:23
Adaptimmune's Cancer Candidate Shows 44% Response Rate In Pretreated Ovarian, Urothelial, Head & Neck Cancers
finviz | 2022年09月09日 19:00
Adaptimmune Reports Positive Data in its SURPASS Trial; Outlines Plans for Advanced Clinical Development in Multiple MAGE-A4 Positive Solid Tumors
finviz | 2022年08月25日 20:00
Adaptimmune to Host Live, Virtual Event to Review Phase 1 SURPASS Trial Data and Outline Plans for Further Development in SURPASS Family of Trials
finviz | 2022年08月10日 18:27
Analysts Have Just Cut Their Adaptimmune Therapeutics plc (NASDAQ:ADAP) Revenue Estimates By 25%
finviz | 2022年08月04日 19:30
Adaptimmune Reports Second-Quarter Financial Results and Business Update
finviz | 2022年08月01日 18:21
Shareholders in Adaptimmune Therapeutics (NASDAQ:ADAP) are in the red if they invested five years ago
finviz | 2022年07月21日 20:00
Adaptimmune to Report Q2 2022 Financial Results and Business Updates on Thursday, August 4, 2022
finviz | 2022年07月02日 04:45
Got $500? 3 Absurdly Cheap Healthcare Stocks That Are Set to Skyrocket
finviz | 2022年07月01日 23:10
What Kind Of Investors Own Most Of Adaptimmune Therapeutics plc (NASDAQ:ADAP)?
finviz | 2022年06月28日 03:27
Why Adaptimmune Therapeutics Stock Is Popping Today
finviz | 2022年06月01日 22:17
We're Not Worried About Adaptimmune Therapeutics' (NASDAQ:ADAP) Cash Burn
finviz | 2022年05月27日 05:00
Clinical Responses Reported across Patient Subgroups with Adaptimmune's Cell Therapy, Afami-cel, Confirming Potential for People with Rare Sarcomas - BLA Submission On-Track
finviz | 2022年05月18日 05:03
Why Shares of Adaptimmune Therapeutics Rose 13.4% on Tuesday
finviz | 2022年05月17日 05:00
Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT
finviz | 2022年05月09日 19:30
Adaptimmune Reports First Quarter Financial Results and Business Update
finviz | 2022年05月04日 20:00
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
首页  上页
下页